Champions Oncology's market cap is currently $90.52M. The company's EPS TTM is $0.02; its P/E ratio is 32.86; Champions Oncology is scheduled to report earnings on September 15, 2025, and the estimated EPS forecast is $0.00. See an overview of income statement, balance sheet, and cash flow financials.
